Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.

NCT00812188 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Symmetric Limited Morphea

Interventions

OTHER: Medium Dose UVA-1
OTHER: High Dose UVA-1

Sponsor

University of Texas Southwestern Medical Center